Quantitative evaluation of p16INK4a promoter methylation using pyrosequencing in de novo diffuse large B-cell lymphoma

The p16INK4a tumor suppressor gene can be inactivated by a variety of events including promoter hypermethylation. In diffuse large B-cell lymphoma (DLBCL), p16INK4a methylation has been associated with advanced disease stage and higher IPI. The prognostic impact of p16INK4a methylation in DLBCL rem...

Full description

Bibliographic Details
Main Authors: Zainuddin, Norafiza, Kanduri, Meena, Berglund, Mattias, Lindell, Monica, Amini, Rose-Marie, Roos, Göran, Sundström, Christer, Enblad , Gunilla, Rosenquist, Richard
Format: Article
Language:English
Published: Pergamon 2011
Subjects:
Online Access:http://irep.iium.edu.my/4588/
http://irep.iium.edu.my/4588/
http://irep.iium.edu.my/4588/
http://irep.iium.edu.my/4588/1/p16.pdf
id iium-4588
recordtype eprints
spelling iium-45882013-06-20T03:00:04Z http://irep.iium.edu.my/4588/ Quantitative evaluation of p16INK4a promoter methylation using pyrosequencing in de novo diffuse large B-cell lymphoma Zainuddin, Norafiza Kanduri, Meena Berglund, Mattias Lindell, Monica Amini, Rose-Marie Roos, Göran Sundström, Christer Enblad , Gunilla Rosenquist, Richard RC0254 Neoplasms. Tumors. Oncology (including Cancer) The p16INK4a tumor suppressor gene can be inactivated by a variety of events including promoter hypermethylation. In diffuse large B-cell lymphoma (DLBCL), p16INK4a methylation has been associated with advanced disease stage and higher IPI. The prognostic impact of p16INK4a methylation in DLBCL remains unclear; however, it has been suggested to correlate with inferior outcome. To further investigate the clinical impact of p16INK4a methylation in DLBCL, promoter methylation of this gene was assessed quantitatively by pyrosequencing. Forty-two of 113 (37%) DLBCL patients with methylation level above 5% were categorized as methylated and subsequently divided into low, intermediate and high methylation categories. Overall, no association was shown between the extent of p16INK4a methylation and patients’ clinical characteristics, except disease stage (P = 0.049). Moreover, we could not reveal any impact of p16INK4a methylation on lymphoma-specific survival. Although >25% of p16INK4a methylation correlated with a better progression-free survival (P = 0.048) in patients <65 years old, the significance of this finding, if any, needs to be further investigated. In conclusion, our finding questions the role of p16INK4a promoter methylation as a negative prognostic factor in DLBCL. Pergamon 2011-04-01 Article PeerReviewed application/pdf en http://irep.iium.edu.my/4588/1/p16.pdf Zainuddin, Norafiza and Kanduri, Meena and Berglund, Mattias and Lindell, Monica and Amini, Rose-Marie and Roos, Göran and Sundström, Christer and Enblad , Gunilla and Rosenquist, Richard (2011) Quantitative evaluation of p16INK4a promoter methylation using pyrosequencing in de novo diffuse large B-cell lymphoma. Leukemia Research, 35 (4). pp. 438-443. ISSN 0145-2126 http://www.sciencedirect.com/science?_ob=ArticleListURL&_method=list&_ArticleListID=1815164858&_sort=r&_st=13&view=c&_acct=C000028758&_version=1&_urlVersion=0&_userid=565570&md5=5d40e637a60dab2a625f6a7b0bd78796&searchtype=a 10.1016/j.leukres.2010.10.001
repository_type Digital Repository
institution_category Local University
institution International Islamic University Malaysia
building IIUM Repository
collection Online Access
language English
topic RC0254 Neoplasms. Tumors. Oncology (including Cancer)
spellingShingle RC0254 Neoplasms. Tumors. Oncology (including Cancer)
Zainuddin, Norafiza
Kanduri, Meena
Berglund, Mattias
Lindell, Monica
Amini, Rose-Marie
Roos, Göran
Sundström, Christer
Enblad , Gunilla
Rosenquist, Richard
Quantitative evaluation of p16INK4a promoter methylation using pyrosequencing in de novo diffuse large B-cell lymphoma
description The p16INK4a tumor suppressor gene can be inactivated by a variety of events including promoter hypermethylation. In diffuse large B-cell lymphoma (DLBCL), p16INK4a methylation has been associated with advanced disease stage and higher IPI. The prognostic impact of p16INK4a methylation in DLBCL remains unclear; however, it has been suggested to correlate with inferior outcome. To further investigate the clinical impact of p16INK4a methylation in DLBCL, promoter methylation of this gene was assessed quantitatively by pyrosequencing. Forty-two of 113 (37%) DLBCL patients with methylation level above 5% were categorized as methylated and subsequently divided into low, intermediate and high methylation categories. Overall, no association was shown between the extent of p16INK4a methylation and patients’ clinical characteristics, except disease stage (P = 0.049). Moreover, we could not reveal any impact of p16INK4a methylation on lymphoma-specific survival. Although >25% of p16INK4a methylation correlated with a better progression-free survival (P = 0.048) in patients <65 years old, the significance of this finding, if any, needs to be further investigated. In conclusion, our finding questions the role of p16INK4a promoter methylation as a negative prognostic factor in DLBCL.
format Article
author Zainuddin, Norafiza
Kanduri, Meena
Berglund, Mattias
Lindell, Monica
Amini, Rose-Marie
Roos, Göran
Sundström, Christer
Enblad , Gunilla
Rosenquist, Richard
author_facet Zainuddin, Norafiza
Kanduri, Meena
Berglund, Mattias
Lindell, Monica
Amini, Rose-Marie
Roos, Göran
Sundström, Christer
Enblad , Gunilla
Rosenquist, Richard
author_sort Zainuddin, Norafiza
title Quantitative evaluation of p16INK4a promoter methylation using pyrosequencing in de novo diffuse large B-cell lymphoma
title_short Quantitative evaluation of p16INK4a promoter methylation using pyrosequencing in de novo diffuse large B-cell lymphoma
title_full Quantitative evaluation of p16INK4a promoter methylation using pyrosequencing in de novo diffuse large B-cell lymphoma
title_fullStr Quantitative evaluation of p16INK4a promoter methylation using pyrosequencing in de novo diffuse large B-cell lymphoma
title_full_unstemmed Quantitative evaluation of p16INK4a promoter methylation using pyrosequencing in de novo diffuse large B-cell lymphoma
title_sort quantitative evaluation of p16ink4a promoter methylation using pyrosequencing in de novo diffuse large b-cell lymphoma
publisher Pergamon
publishDate 2011
url http://irep.iium.edu.my/4588/
http://irep.iium.edu.my/4588/
http://irep.iium.edu.my/4588/
http://irep.iium.edu.my/4588/1/p16.pdf
first_indexed 2018-09-07T03:11:55Z
last_indexed 2018-09-07T03:11:55Z
_version_ 1610916734716346368